Suppressive Effects of D-Glucosamine on the 5-HT Sensitive Nociceptive Units in the Rat Tooth Pulpal Nerve

It is well known that D-glucosamine hydrochloride (DGL) has a variety of biological activities and is regarded as a nutritional supplement effective in improving various disorders, including osteoarthritis and atherosclerosis. Although it has been reported that DGL has a significant pain relief effect in treating osteoarthritis, little is known about the characteristics of the effects of this compound on dental pain. The present study was undertaken to evaluate the applicability of DGL as a medicament to control pulpalgia. Using an in vitro rat mandible-inferior alveolar nerve preparation (jaw-nerve preparation), we evaluated the effects of DGL on 5-hydroxytryptamine (5-HT) sensitive nociceptive responses in the tooth pulpal nerve. 5-HT-induced nociceptive responses were fairly suppressed by direct application of DGL, suggesting that DGL have a pain relief effect on patients with dental pain.

[1]  J. Hua,et al.  Evaluation of the suppressive actions of glucosamine on the interleukin-1β-mediated activation of synoviocytes , 2007, Inflammation Research.

[2]  Y. Shigemasa,et al.  Applications of chitin and chitosan for biomaterials. , 1996, Biotechnology & genetic engineering reviews.

[3]  D. Reda,et al.  The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. , 2008, Arthritis and rheumatism.

[4]  E. Roos,et al.  Clinical update: treating osteoarthritis , 2007, The Lancet.

[5]  Eric Lejeune,et al.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.

[6]  I. B. Bender.  Pulpal pain diagnosis--a review. , 2000, Journal of endodontics.

[7]  K. Pavelka,et al.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. , 2002, Archives of internal medicine.

[8]  Millar Tm.  Treatment of carcinoma of the rectosigmoid region. , 1947 .

[9]  A. Moriondo,et al.  Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide , 2001, The Journal of physiology.

[10]  Shizuka Yamada,et al.  Chitosan monomer promotes tissue regeneration on dental pulp wounds. , 2006, Journal of biomedical materials research. Part A.

[11]  R. Muzzarelli,et al.  Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. , 1999, EXS.

[12]  G. Bennett,et al.  Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine , 2008, PAIN.

[13]  S. Shulman,et al.  Clinical aspects of acute rheumatic fever. , 1991, The Journal of rheumatology. Supplement.

[14]  K. Toda,et al.  An in vitro jaw-nerve preparation for oral sensory study in the rat , 1995, Journal of Neuroscience Methods.

[15]  A. Lopes Vaz.  Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. , 1982, Current medical research and opinion.

[16]  P. Jollès,et al.  Chitin and chitinases. , 1999 .

[17]  A. Bignamini,et al.  Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. , 1980, Clinical therapeutics.

[18]  G. Scali,et al.  Glucosamine sulphate: a controlled clinical investigation in arthrosis. , 1981, Pharmatherapeutica.

[19]  J. Peyron,et al.  A Risk-Benefit Assessment of Injections of Hyaluronan and its Derivatives in the Treatment of Osteoarthritis of the Knee , 2000, Drug safety.

[20]  M. Hiligsmann,et al.  Glucosamine sulphate in the treatment of knee osteoarthritis: cost‐effectiveness comparison with paracetamol , 2010, International journal of clinical practice.

[21]  A. L. Vaz.  Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients , 1982 .

[22]  M. Pfeffer,et al.  Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. , 2007, European heart journal.

[23]  L. Premkumar,et al.  Induction of vanilloid receptor channel activity by protein kinase C , 2000, Nature.

[24]  D. Felson,et al.  Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.

[25]  P. Revell,et al.  EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON COURSE OF OSTEOARTHRITIS , 1989, The Lancet.

[26]  K. Iwabuchi,et al.  Glucosamine, a naturally occurring amino monosaccharide, suppresses the ADP-mediated platelet activation in humans , 2004, Inflammation Research.

[27]  J. Pujalte,et al.  Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. , 1980, Current Medical Research and Opinion.

[28]  Martin Michaelis,et al.  Osteoarthritis — an untreatable disease? , 2005, Nature Reviews Drug Discovery.

[29]  S. Waxman,et al.  The roles of sodium channels in nociception: Implications for mechanisms of pain , 2007, PAIN.

[30]  R. Ling,et al.  ACETABULAR BONE DESTRUCTION RELATED TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS , 1985, The Lancet.

[31]  E. Stevens,et al.  The role of sodium channels in neuropathic pain. , 2006, Seminars in cell & developmental biology.

[32]  H. Zeidler.  Epidemiology of NSAID-induced gastropathy , 1991, Clinical Rheumatology.

[33]  Y. Vajaradul.  Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. , 1981, Clinical therapeutics.

[34]  K. Bielefeldt,et al.  TRPV1 Function in Mouse Colon Sensory Neurons Is Enhanced by Metabotropic 5-Hydroxytryptamine Receptor Activation , 2004, The Journal of Neuroscience.

[35]  E. D’Este,et al.  Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. , 1980, Current medical research and opinion.

[36]  A. Marty,et al.  Action of glucosamine on acetylcholine-sensitive channels , 1980, The Journal of Membrane Biology.

[37]  J. Hua,et al.  Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats , 2005, Inflammation Research.

[38]  J. Hua,et al.  Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils , 2002, Journal of leukocyte biology.